Super Crop Safe board to meet on May 30 for Q4FY26 results
Super Crop Safe Limited will hold its 238th board meeting on May 30, 2026, to consider the audited financial results for the quarter and year ended March 31, 2026, along with other regulatory matters.

*this image is generated using AI for illustrative purposes only.
Super Crop Safe Limited has announced that its 238th board meeting is scheduled to take place on May 30, 2026. The meeting will be convened at the company's registered office at 1:00 p.m. to discuss key agenda items related to the company's financial performance and governance matters.
The primary agenda for the meeting is the consideration of the audited financial results for the last quarter and the financial year ended March 31, 2026. This review will be conducted in accordance with Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015.
Agenda Items
The board will deliberate on several specific points during the session. The key items to be considered include:
- Audited financial results for the quarter and year ended March 31, 2026.
- Disclosure of interest by directors.
- Disclosure on disqualification by directors.
- Any other matter with the permission of the chair.
The meeting details and agenda have been formally communicated to the Bombay Stock Exchange Limited. The company has requested the exchange to place the intimation on record for the benefit of shareholders and the market.
Historical Stock Returns for Super Crop Safe
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.50% | -9.58% | +5.82% | +24.22% | -31.03% | +17.65% |
How might Super Crop Safe Limited's audited financial results for FY2026 compare to the previous year, and what revenue growth trends could emerge from the agrochemical sector's performance?
Will the board consider declaring any dividends or announcing capital allocation strategies following the review of FY2026 financial results?
Are there any anticipated changes in board composition or director disclosures that could signal shifts in the company's governance or strategic direction?






























